Research Article
Network Pharmacology Approach to Explore the Potential Mechanisms of Jieduan-Niwan Formula Treating Acute-on-Chronic Liver Failure
Table 2
The information of top 20 pathways.
| GO ID | Description | Gene number | P value | Rich factor |
| hsa05200 | Pathways in cancer | 72 | 2.52152E-76 | 0.125217391 | hsa05161 | Hepatitis B | 39 | 2.54498E-50 | 0.220338983 | ko04933 | AGE-RAGE signaling pathway in diabetic complications | 32 | 2.4597E-47 | 0.323232323 | hsa05205 | Proteoglycans in cancer | 34 | 2.48392E-38 | 0.155963303 | hsa04668 | TNF signaling pathway | 28 | 1.72293E-37 | 0.243478261 | hsa05162 | Measles | 30 | 1.40858E-36 | 0.189873418 | hsa01524 | Platinum drug resistance | 19 | 2.58784E-26 | 0.260273973 | hsa04926 | Relaxin signaling pathway | 20 | 2.80746E-22 | 0.147058824 | ko05144 | Malaria | 15 | 3.29022E-22 | 0.306122449 | hsa05202 | Transcriptional misregulation in cancer | 21 | 5.13459E-20 | 0.102941176 | ko04917 | Prolactin signaling pathway | 14 | 6.54424E-18 | 0.2 | hsa04024 | cAMP signaling pathway | 20 | 8.3844E-18 | 0.088495575 | hsa04919 | Thyroid hormone signaling pathway | 16 | 3.71782E-17 | 0.130081301 | ko04012 | ErbB signaling pathway | 14 | 1.4152E-16 | 0.162790698 | ko05134 | Legionellosis | 12 | 5.14222E-16 | 0.218181818 | ko04152 | AMPK signaling pathway | 14 | 1.75187E-14 | 0.116666667 | hsa04910 | Insulin signaling pathway | 14 | 6.32339E-13 | 0.090322581 | hsa04610 | Complement and coagulation cascades | 11 | 6.37071E-12 | 0.123595506 | ko04020 | Calcium signaling pathway | 13 | 8.49125E-11 | 0.071428571 | hsa05330 | Allograft rejection | 8 | 3.66628E-10 | 0.170212766 |
|
|